Concepedia

E. Calvo-Aller

EC

Statistics

Publications

2

Citations

62

H-Index

2

Active since

2008

E. Calvo-Aller is an author specializing in cancer pharmacology, pharmacodynamics of anticancer agents, and pharmacology.

Publications per year

2008–2008

2

Publications

2

First human dose escalation study in patients with metastatic malignancies to determine safety and pharmacokinetics of LY2157299, a small molecule inhibitor of the transforming growth factor-beta receptor I kinase

E. Calvo-Aller, José Baselga, Sophie Glatt et al. · Journal of Clinical Oncology · 2008 · 39 citations

, , +16

Phase I multicenter trial of BMS-690514: Safety, pharmacokinetic profile, biological effects, and early clinical evaluation in patients with advanced solid tumors and non-small cell lung cancer

Ratio Bahleda, Enriqueta Felip, Ronald Herbst et al. · Journal of Clinical Oncology · 2008 · 23 citations

, , +17

1–2 of 2